Science
Myeloma Paper of the Day, September 29th, Suggested by Robert Orlowski

Myeloma Paper of the Day, September 29th, Suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:

“Myeloma Paper of the Day:

Phase 2 IZALCO study in RRMM w/ sc isatuximab via on-body injector versus manual injection finds both patients (74.5% (35/47)) and HCPs (78.9% (15/19)) prefer the OBI to sc manual injection.”

Title: Patient-reported Outcomes and Healthcare Provider Perspectives on Subcutaneous Isatuximab Delivery via On-body Injector Versus Manual Injection: Results From the Phase 2 IZALCO Study in RRMM

Authors: Gurdeep Parmar, Marcelo Capra, Vania Hungria, Fernanda Salles Seguro, Meletios-Athanasios Dimopoulos, Sosana Delimpasi, Ivan Špička, Jiří Minařík, Herlander Marques, Ludĕk Pour, Jana Mihályová, Junichiro Yuda, Kazutaka Sunami, Graça Esteves, Cynthia Chmielewski, Christine Soufflet, Disa Yu, Erin Comerford, Florence Suzan, Paul Cordero, Rick Zhang, Hang Quach

You can read the full article on Clinical Lymphoma, Myeloma and Leukemia.

Myeloma Paper of the Day, September 29th, Suggested by Robert Orlowski

You can find other articles featuring Robert Orlowski on OncoDaily.

cancer Christine Soufflet Clinical Lymphoma Clinical Lymphoma Myeloma and Leukemia Cynthia Chmielewski Disa Yu Erin Comerford Fernanda Salles Seguro Florence Suzan Graça Esteves Gurdeep Parmar Hang Quach Herlander Marques Ivan Spicka Jana Mihalyova Jiří Minařík Junichiro Yuda Kazutaka Sunami Luděk Pour Marcelo Capra Meletios-Athanasios Dimopoulos Myeloma Paper of the Day OncoDaily Oncology Paul Cordero Rick Zhang Robert Orlowski Sosana Delimpasi Vania Hungria